PGNY
USDProgyny Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$18.280
Haut
$18.840
Bas
$18.030
Volume
0.61M
Fondamentaux de l'Entreprise
Capitalisation Boursière
1.6B
Industrie
Healthcare Plans
Pays
United States
Statistiques de Trading
Volume Moyen
1.31M
Bourse
NMS
Devise
USD
Intervalle sur 52 Semaines
Rapport d'Analyse IA
Dernière mise à jour: 3 nov. 2025PGNY Stock Analysis: What Progyny's Recent Moves Mean for Short-Term Traders
What's Happening With Progyny Right Now
Progyny (PGNY) is showing signs of exhaustion after a rough few months. The stock closed at $18.43 on November 3rd, down from $23 in early August--a nearly 20% slide over the past three months. The chart tells a clear story: persistent selling pressure with occasional spikes when news hits. Volume exploded to over 7.4 million shares on October 16th when the stock jumped 4.7% in one day, only to crash
Actualités Connexes
Progyny, Inc. Announces Details for Its Third Quarter 2025 Results Report
NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a global leader in women's health and family building solutions, will report its financial results for the quarterly period ended September 30,
Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and Menopause
NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a global leader in women's health and family building solutions, today announced the launch of its pregnancy, postpartum, and menopause programs
Transcarent Experience Store Expansion: More Options for Women's Health
Maven Clinic, Midi Health, and Progyny provide support for menopause, perimenopause, and family building for Transcarent Members Easy access through WayFinding™ AI experience is a gamechanger Transcarent, the
Progyny CEO Named World Economic Forum Champion for Women's Health
NEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a global leader in women's health and family building solutions, today announced that CEO Pete Anevski has been honored with the recognition as a
Prédiction IABeta
Recommandation IA
Mis à jour le: 4 nov. 2025, 17:26
64.3% Confiance
Risque et Trading
Point d'Entrée
$18.21
Prise de Bénéfices
$19.66
Stop Loss
$16.58
Facteurs Clés
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.